August 28, 2007
Healthcare Executive, Bruce Vladeck, Returns to Ernst & Young
NEW YORK, Aug. 28 /PRNewswire/ -- Bruce Vladeck returns to Ernst & Young LLP as an Executive Director with the firm's Health Sciences Advisory Services (HSAS) practice. Vladeck re-joins Ernst & Young after serving sixteen months as the interim president of the University of Medicine and Dentistry of New Jersey (UMDNJ) at the request of New Jersey Governor Jon Corzine. Vladeck will serve as a Senior Health Policy Advisor for the firm.
While at UMDNJ, Vladeck's accomplishments included: -- Working with the Governor's Office and Chairman of the Board of Trustees to reconstitute the membership, structure, and operations of University governance to comply with contemporary standards of accountability, board development, and appropriate oversight of management. -- Directing completion of Fiscal 2005 and 2006 audited financial statements and A-133 (federal and state grant) audits, along with a restatement of Fiscal 2004 results. -- Reducing the university-wide budget deficit from roughly $45 million in Fiscal '06 to zero in Fiscal '08. This was achieved largely through management and operational changes at University Hospital which produced cost reductions and revenue enhancements worth in excess of $50 million annually.
"Bruce's experience in healthcare policy will be a tremendous asset to our firm, particularly at a time when regulators are proposing major healthcare reforms. Right now, our clients are struggling with how to manage the risks of today's social and political environment, while preparing for and understanding the implications of proposed reforms," said Rick Wallace, managing partner, HSAS.
Among other duties, Bruce will be the East Coast director for the practice's academic medical center practice, and focus on issues such as graduate medical education, policy strategy, cost management, reimbursement, and compliance.
From 1993 to 1997, Vladeck was administrator of the Health Care Financing Administration (HCFA) of the U.S. Department of Health and Human Services. In that role, he directed the Medicare and Medicaid programs providing health insurance to more than 65 million Americans. At the state-level, Vladeck served as the assistant commissioner for health planning and resources development with the New Jersey Department of Health from 1979 to 1982. He was previously with Ernst & Young from 2004 until he assumed his duties at UMDNJ.
Vladeck previously taught at Columbia University and the Mount Sinai School of Medicine in New York, and spent ten years as the President of the United Hospital Fund of New York. He is a member of the New York City Board of Health, and a Trustee of the March of Dimes and the Medicare Rights Center.
Vladeck is a graduate of Harvard College and the University of Michigan, where he received his Ph.D. in political science. Vladeck's awards include the 1998 President's Award of the American Society on Aging. Vladeck is also the author of Unloving Care: The Nursing Home Tragedy.
For more information about Ernst & Young LLP's HSAS practice visit: http://www.ey.com/us/healthsciences. About Ernst & Young
Ernst & Young, a global leader in professional services, is committed to restoring the public's trust in professional services firms and in the quality of financial reporting. Its 114,000 people in 140 countries pursue the highest levels of integrity, quality, and professionalism in providing a range of sophisticated services centered on our core competencies of auditing, accounting, tax, and transactions. Further information about Ernst & Young and its approach to a variety of business issues can be found at http://www.ey.com/perspectives. Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, a U.K. company limited by guarantee, each of which is a separate legal entity. Ernst & Young Global Limited does not provide services to clients. Ernst & Young LLP is a U.S. client-serving member firm of Ernst & Young Global Limited.
Ernst & Young
CONTACT: Michelle Wolf, Ernst & Young LLP, +1-212-773-6496,[email protected]
Web site: http://www.ey.com/perspectiveshttp://www.ey.com/us/healthsciences